menu
    • menu
    [{"orgOrder":0,"company":"Evio Labs","sponsor":"Leading Edge Pharms","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"U.S.A","productType":"Controlled Substance","year":"2021","type":"Acquisition","leadProduct":"Cannabidiol","moa":"||Cannabinoid CB1 receptor","graph1":"Neurology","graph2":"Approved FDF","graph3":"Evio Labs","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Ointment","sponsorNew":"Evio Labs \/ Evio Labs","highestDevelopmentStatusID":"15","companyTruncated":"Evio Labs \/ Evio Labs"}]

    Find Clinical Drug Pipeline Developments & Deals by Evio Labs

    Menu

    Evio Labs

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Evio Labs

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Evio Labs

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cannabidiol,Eugenia Caryophyllus Flower Oil,Rosmarinus Officinalis Leaf Extract

                            Therapeutic Area : Neurology

                            Study Phase : Approved FDF

                            Recipient : Leading Edge Pharms

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            EVIO, Inc. Enters Into Letter of Intent to Acquire Leading Edge Pharms, Inc.

                            Details : LEP has formulated a line of products including CANNAVERA™, a family of topical pain relief products currently pending for over-the-counter (OTC) registration with the FDA.

                            Product Name : Cannavera

                            Product Type : Controlled Substance

                            Upfront Cash : Undisclosed

                            July 12, 2021

                            Lead Product(s) : Cannabidiol,Eugenia Caryophyllus Flower Oil,Rosmarinus Officinalis Leaf Extract

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved FDF

                            Recipient : Leading Edge Pharms

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth